Bristol Myers Squibb Presents New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy at Upcoming American College of Cardiology’s 70th Annual Scientific Session – Business Wire
CONTEXT: Presentation of RWD on Mavacamten in obstructive hypertrophic cardiomyopathy by MS at the ACC annual scientific session being held virtually this year. BMS following an increasing trend od presenting Continue Reading